Transnasal-Transoral Endoscopic Surgery Followed by Radiotherapy for Nasopharyngeal Spindle Cell Carcinoma

经鼻-经口内镜手术联合放射治疗鼻咽梭形细胞癌

阅读:1

Abstract

Spindle cell carcinoma (SpCC) is a rare and aggressive variant of squamous cell carcinoma characterized by the coexistence of epithelial and mesenchymal components, accounting for <1% of all head and neck malignancies. Nasopharyngeal SpCC is extremely rare, and its optimal management remains unclear, particularly in patients who cannot tolerate extensive surgery. An 80-year-old man presenting with right-sided ear fullness was diagnosed with nasopharyngeal SpCC (T1N0M0). Imaging revealed a submucosal tumor on the posterior wall of the nasopharynx that was in contact with the right Eustachian tube. The patient also had severe chronic kidney disease; therefore, conventional open approaches requiring prolonged operative time and significant surgical stress were considered unsuitable. Therefore, a combined transnasal-transoral endoscopic approach was selected to achieve maximal tumor reduction while minimizing surgical invasiveness. This approach provides a wide and complementary surgical view of the nasopharynx, enabling precise dissection of tumor margins extending cranially and caudally beyond the soft palate. Intraoperatively, the Eustachian tube was clearly visualized and confirmed to be intact. Histopathological examination revealed SpCC with a positive surgical margin on the posterior nasopharyngeal wall. Postoperative radiotherapy was administered to the surgical bed with positive margins. The patient achieved disease-free survival for >3 years after surgery, with stable perioperative renal function. This case highlights the advantages of the transnasal-transoral endoscopic approach in providing adequate visualization and access to the nasopharynx while reducing surgical morbidity. The combination of maximal cytoreductive endoscopic surgery and postoperative radiotherapy may represent an effective and less invasive treatment option for nasopharyngeal SpCC, particularly in patients with significant comorbidities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。